破解CDK4/6抑制剂耐药性的基因组代码
Seth A Wander1, Aditya Bardia2
1Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
概括
激素受体阳性转移性乳腺癌 (HR+/HER2-MBC) 的治疗正在使用循环素依赖性激酶4/6抑制剂 (CDK4/6i) 进行. 现在的研究重点是了解耐药机制,以改进未来的治疗方法.
科学领域:
- 在瘤学瘤学.
- 翻译性乳腺癌研究
背景情况:
- 转移性激素受体阳性,人体表皮生长因子-2-阴性乳腺癌 (HR+/HER2-MBC) 治疗已取得显著进展.
- 循环素依赖性激酶4/6抑制剂 (CDK4/6i) 现在是标准的第一线疗法,与抗雌激素一起使用.
研究的目的:
- 探索HR+/HER2- MBC不断变化的治疗场景.
- 调查基因组和分子机制,以抵御目前的疗法,包括抗雌激素和CDK4/6抑制剂.
主要方法:
- 关于HR+/HER2-MBC治疗的当前临床和研究文献的审查.
- 对新出现的治疗药物和耐药性途径的分析.
主要成果:
- CDK4/6抑制剂代表了HR+/HER2- MBC治疗的重大治疗进展.
- 新型抗雌激素,信号转导抑制剂和下一代CDK抑制剂正在开发中.
- 了解耐药机制对于未来的治疗策略至关重要.
结论:
- HR+/HER2-MBC的治疗是动态的,新疗法正在不断开发.
- 识别和克服对CDK4/6抑制剂和抗雌激素的耐药性是关键的研究优先事项.
更多相关视频
相关概念视频
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
M-Cdk Drives Transition Into Mitosis
5.6K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Negative Regulator Molecules
35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K


